scholarly journals Effect of Different Education Modes on Disease Recognition and Compliance in Patients with Type 2 Diabetes

2019 ◽  
Vol 3 (6) ◽  
Author(s):  
Lei Ma ◽  
Shujin Wang ◽  
Lihong Fan ◽  
Xiaoyang Liu ◽  
Tiao Bai ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Health Service ◽  
Community Health ◽  
Community Health Service ◽  
Service Center ◽  
Educational Models ◽  
Education Group ◽  
Group I ◽  
Group Ii

Objective: To explore the impact of different educational models on disease recognition and compliance in patients with type 2 diabetes. Methods: For 100 patients with type 2 diabetes who were filed at the Changyanbao Community Health Service Center and the Electronic City Community Health Service Center from January 2017 to January 2018, the patients with diabetes were divided into 50 patients in the patient education group (group I) and 50 patients in the comprehensive education group (group II) according to the order of establishment. Observe the effects of different educational models on disease recognition and compliance in patients with type 2 diabetes. Results: After the relevant education, the effects of disease recognition and compliance were significantly higher in both groups (P<0.05), but the disease recognition and compliance of the patients in group II were significantly better than patients in group I (P<0.05). Conclusion: Through a variety of diabetes education models, and the network medical platform, patients can effectively improve disease awareness and compliance, thereby further control blood sugar, and improve patient quality of life.

scholarly journals Study of the Osteoporotic Changes in Postmenopausal Women with Type-2 Diabetes Mellitus

2017 ◽  
Vol 18 (1) ◽  
pp. 21-26
Author(s):  
Ayesha Jahan ◽  
Rokeya Begum ◽  
Khaled Bin Shamsuddin
Keyword(s):  
Diabetes Mellitus ◽  
Bone Mineral Density ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Femoral Neck ◽  
Postmenopausal Women ◽  
Mineral Density ◽  
Group I ◽  
Group Ii

Introduction: Osteoporosis and Diabetes Mellitus (DM) are common medical conditions in the society with an increasing prevalence in elderly people. Osteoporosis is more common in female than male and postmenopausal women are vulnerable to it.   Objective: The aim of this study was to verify the effect of type-2 diabetes mellitus on bone mineral density in postmenopausal women and, thereby, to evaluate the risk of osteoporosis in them.   Materials and Methods: This cross-sectional study was carried out at National institute of Nuclear Medicine and Allied Sciences (NINMAS), BSMMU campus, Shahbagh, Dhaka, over a period of one year. 175 postmenopausal women were enrolled as study subjects, among them 72 (41.10%) were diabetic and rest 103 (59.90%) were nondiabetic and they were assigned as Group-I and Group-II respectively. The bone mineral density (BMD) was measured by central DEXA device at lumbar spines and left femoral neck of each study subject.   Results: The mean (±SD) ages of group-I and group-II were 58.79 (±8.06) and 58.27 (±8.39) respectively with an age range of 45 to 75 years in both cases. A total of 30 (41.66%) patients in diabetic group (group-I) and 40 (38.83%) patients in non-diabetic (group-II) had osteoporosis at lumbar spines. On the other hand, 40 (56.94%) patients in group-I and 58 (56.31%) patients in group-II had osteoporosis at femoral neck. The Odds Ratios of osteoporosis for lumbar spines and femoral. neck were 1.125 and 1.026 respectively. The differences of frequencies of osteoporosis between group-I and group-II were not statistically significant at any anatomical site and the association between osteoporosis and type-2 diabetes mellitus was not significant. According to Odds Ratio type-2 diabetes mellitus was not a risk factor for developing osteoporosis in postmenopausal women.   Conclusion: Postmenopausal women are prone to develop osteoporosis and type-2 diabetes mellitus may have adverse influence on osteoporosis, which was supported by few previous studies. This study could not establish any significant effect of type-2 diabetes mellitus on osteoporosis in postmenopausal women.Bangladesh J. Nuclear Med. 18(1): 21-26, January 2015

scholarly journals Renoprotective opportunities of Lespedeza capitata in patients with chronic kidney disease and type 2 diabetes mellitus

KIDNEYS ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 162-168
Author(s):  
S.V. Kushnirenko ◽  
D.D. Ivanov ◽  
S.A. Rotova ◽  
О.V. Kushnirenko
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Antihypertensive Therapy ◽  
Glucose Lowering ◽  
Type 2 Dm ◽  
Group I ◽  
Ckd Stage ◽  
Lespedeza Capitata ◽  
Group Ii

Background. Today, issues of renoprotection have gone beyond the use of antihypertensive therapy alone. Stable glucose-lowering and urate-lowering therapy are integral parts of modern renoprotection, which improve the functional state of the kidneys by increasing the glomerular filtration rate (GFR) and reducing the albumin excretion rate (AER) and the albumin-to-creatinine ratio (ACR). Nevertheless, hypoazotemic therapy aimed at reducing the content of nitrogenous wastes remains the leading component of the treatment of patients with chronic kidney disease (CKD). The aim of the study is the assessment of the renoprotective potential of the drug Libera (Lespedeza capitata) in patients with CKD stages 2–3 on the background of type 2 diabetes mellitus (DM). Materials and methods. The study included 107 patients with type 2 DM, aged 19 to 75 years (female — 41.1 %, male — 58.9 %), CKD stages 2–3, micro- and macroalbuminuria (category A2 and A3). The patients were divided into two groups: group I — traditional stable glucose-lowering and antihypertensive therapy (n = 50) and group II — traditional stable glucose-lowering and antihypertensive therapy in combination with Libera (Lespedeza capitata) (n = 57), which was prescribed 1 capsule t.i.d. regardless of food intake for 3 months. The criteria for the effectiveness of treatment were dynamics of GFR, AER/ACR in daily urine. The observation period for the patients was 3 months. Results. The renoprotective potential of Lespedeza capitata (Libera) was demonstrated after 3 months of treatment in the form of a significant increase in GFR in patients with CKD stage 2 in group II up to 79.0 ± 1.4 ml/min/1.73 m2 in comparison with the initial data (p < 0.01) and the results obtained in group I after 3 months of using only traditional stable glucose-lowering and antihypertensive therapy (p < 0.05). The use of Libera in the complex treatment of patients of the II group with CKD stage 3 against the background of type 2 DM for 3 months had a positive effect on nitrogen and water excretory kidney function, which manifested itself in an improvement in GFR to 56.6 ± 2.1 ml/min/1.73 m2 in comparison with the initial data (p < 0.05) and the results obtained in group I — 50.8 ± 1.9 ml/min/1.73 m2 (p < 0.05). In group I with traditional stable glucose-lowering and antihypertensive therapy, only 3 patients (9.1 %) transferred from category A2 to category A1 (normoalbuminuria) after 3 months and 2 patients (11.8 %) from category A3 to category A2. In group II, the appointment of Lespedeza capitata (Libera) in combination with stable glucose-lowering and antihypertensive therapy facilitated the transfer of 10 patients (27.8 %) from category A2 to A1 and 7 patients (33.3 %) from category A3 to A2 (p < 0.001). Conclusions. Lespedeza capitata (Libera) in combination with traditional stable glucose-lowering and antihypertensive therapy contributes to the preservation and improvement of the filtration function of the kidneys, a decrease in AER/ACR in patients with CKD stage 2–3 (3a і 3b) against the background of type 2 DM and proves renoprotective efficiency and safety.

scholarly journals Autoantibody as markers of the heart state in patients with vibration disease burdened diabetes mellitus

2020 ◽  
Vol 22 (2) ◽  
pp. 311-318
Author(s):  
L. B. Masnavieva ◽  
I. V. Kudaeva ◽  
Yu. A. Kuznetsova
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Thrombus Formation ◽  
The State ◽  
Myocardial Cells ◽  
Diabetes Group ◽  
Vibration Disease ◽  
Group I ◽  
Group Ii

Physical and chemical factors, obesity, lipid metabolism disorder, diabetes affect the state of the vascular endothelium, the processes of thrombus formation, fibrinolysis and increase the risk of developing cardiovascular diseases. It can be assumed that the development and course of pathological processes in the cardiovascular system, caused by vibration disease with the onset of diabetes, will undergo changes. The purpose of the study was to assess the state of heart condition according to the level of specific autoantibodies with the combined effect of vibration disease and type 2 diabetes mellitus. Patients with vibration disease (group I), patients with type 2 diabetes (group II) and persons with vibration disease in combination with type 2 diabetes (group III) were examined. Individuals do not have a history of coronary heart disease, stroke, and myocardial infarction have been included in obsledrovanie. Serum levels of specific autoantibodies characterizing the state of the heart have been studied. It was revealed that the content of autoantibodies to 1-adrenoreceptors in patients of group I was higher than in individuals of group II. The relative content of autoantibodies to the components of the membrane and cytoplasm of myocardial cells in patients of groups I-III did not differ. It was found that elevated levels of autoantibodies to components of the membrane and cytoplasm of myocardial cells, cardiomyosin, 1-adrenoreceptors were observed more often in patients with vibration disease combined with diabetes and in persons with vibration disease than in people with diabetes. Persons with a reduced content of autoantibodies to 1-adrenergic receptors were not detected among patients of groups I and III. Changes in the levels of specific autoantibodies in persons with vibration disease may indicate the development of functional metabolic and structural changes in the heart, disorders of its electrical activity that have not yet been manifested in the form of a pathological process. Lower levels of 1-adrenoceptor autoantibodies in patients with type 2 diabetes without vibration disease can be caused by increased levels of catecholamines, which is characteristic of diabetics. Further research, including clinical data and indicators of functional diagnostics is necessary to confirm our assumptions.

scholarly journals Combined Management can Decrease Blood Pressure: A Health-seeking Behaviors Investigation among Hypertensive Patients in Urban Communities in China

2021 ◽  
Author(s):  
Si Wang ◽  
Kai Liu ◽  
Xin Zhang ◽  
Qingtao Meng ◽  
Xinran Li ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Health Service ◽  
Community Health ◽  
Urban Communities ◽  
Community Health Service ◽  
Service Center ◽  
Health Seeking ◽  
Hypertensive Patients ◽  
Health Seeking Behaviors ◽  
Medical Facilities

Abstract Background: Hypertensive patients can freely choose the informal medical facilities such as pharmacies, community health service centers, and cardiology clinics in secondary or tertiary hospitals, as the routine places for medical treatment in China at present. It is not clear the proportion, influencing factors and the effects on blood pressure (BP) of different health-seeking behaviors among hypertensive patients in urban communities. The aim of the study is to investigate the health-seeking behaviors and the effect on BP of different health-seeking behaviors among hypertensive patients in urban communities in China.Methods: A cross-sectional survey of hypertension was conducted in urban communities in Chengdu. 437 hypertensive patients seeking medical help regularly were sequentially enrolled to fill out the questionnaire on health-seeking behaviors.Results: The average age was 67.1±7.5 years. Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were 144.2±17.9 mmHg and 75.4±10.4 mmHg, respectively, and the control rate of BP was 41.0%. Among the hypertensive patients investigated, 5.2% of which chose the informal medical facilities, 62.8% chose the community health service center, 21.5% chose the cardiology clinics in secondary or tertiary hospitals, and 10.5% chose both community health service center and cardiology clinics as the usual places for medical treatment. There were statistical differences in education levels, proportions of home BP monitoring, establishing chronic disease archives in community, medication compliance and side effects of drugs among the four groups. The SBP was 150.9 ±19.8, 145.1±18.0, 143.8±17.5 and 136.3±15.1 mmHg (P=0.007) in the four groups respectively and it was significantly lower in the combined management group than in the other three groups. The control rate of BP was 23.8%, 39.4%, 43.0% and 54.8% (P=0.100), respectively. Compared with patients choosing the informal medical facilities, patients in the combined management group had significant higher BP control rate (OR = 3.679, P = 0.035).Conclusions: Combined management with both community health service center and higher-level hospitals can decrease BP.

scholarly journals Risk factors for the frequent attendance of older patients at community health service centers in China: a cross-sectional study based on stratified sampling

2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Nana Li ◽  
Juan Shou
Keyword(s):  
Risk Factors ◽  
Health Service ◽  
Community Health ◽  
Chronic Diseases ◽  
Cross Sectional Study ◽  
Community Health Service ◽  
Service Center ◽  
Sectional Study ◽  
Cross Sectional ◽  
Frequent Attendance

Abstract Background This study aimed to investigate the characteristics of frequent attenders (FAs) among older patients in Shanghai, China, and explore the associated factors. Methods This cross-sectional study was conducted in six community health service centers in Shanghai, China, from August to December 2018 based on stratified sampling. On the basis of our preliminary study, FAs were defined as those attending at least four consultations in a month. A self-administered questionnaire was used to collect the clinicodemographic data of the participants. Social support, pain severity, depression, and anxiety were evaluated using the Social Support Revalued Scale, six-point Behavioral Rating Scale, Patient Health Questionnaire–9, and Generalized Anxiety Disorder Scale, respectively. Results This study included 619 patients aged > 60 years. Among these patients, 155 (25%) were FAs to a community health service center, 366 (59.1%) had 1 or 2 chronic diseases, 179 (28.9%) had ≥3 chronic diseases, 313 (50.4%) opted for a family doctor service, and 537 (86.8%) chose a community health service center for the first consultation. The following were identified as independent risk factors for frequent attendance: widowed status, unmarried status, the presence of > 3 chronic diseases, first consultation at a community health service center, high medical expenses, frequent attendance of the spouses, long-term medication, the use of both traditional Chinese and Western medicine services, and depression. Conclusions This study summarizes the characteristics of older FAs to community health service centers in China and identifies 10 risk factors significantly associated with frequent attendance.

Impact of intelligent family physician optimized coordination model On Primary Hypertension Patients in a Beijing Community (Preprint)

2019 ◽  
Author(s):  
Dan Li ◽  
Xuejuan Wei ◽  
Hao Wu ◽  
Xing-Ying Liu ◽  
Wen-Juan Gao
Keyword(s):  
Health Service ◽  
Community Health ◽  
Chronic Diseases ◽  
Family Physician ◽  
Community Health Service ◽  
Lifestyle Changes ◽  
Categorical Variables ◽  
Service Center ◽  
Patient Centered ◽  
Collaborative Model

BACKGROUND In order to address the challenges of chronic diseases, Beijing Municipal Government promoted intelligent family physician optimized collaborative model ( IFOC ) schema, which is poised to implement the patient-centered healthcare model, supported by intelligent chronic disease management system. The Fangzhuang community health service center is a National Demonstration Community Health Service Center in China, laid emphasis on the patient-centered model service, initiated, piloted and promoted IFOC schema optimize management of chronic diseases. OBJECTIVE To explore the effect of an intelligent family physician optimized collaborative model on selected hypertension patients of Fangzhuang Community in Beijing. METHODS This retrospective study used de-identified data of hypertension patients from the database of Fangzhuang community health service center. A comparative study pre- and post-implementation of IFOC for 2 years was performed to evaluate standardized management rate of blood pressure (BP), BP values, BP control rate, lifestyle changes and blood lipid levels. Continuous variables and categorical variables were analyzed using paired t-test and χ2 test, respectively. RESULTS A total of 6929 hypertension cases met inclusion/exclusion criteria. Compared with the pre-index period, standardized management rate increased from 34.4% to 67.4% in the post-index period (p < 0.001). SBP decreased from 144.10 mmHg to 141.38 mmHg (p < 0.001). BP control rate of the high-risk patients and overall BP control rate enhanced from 35.2% to 48.8%, from 44.7% to 49.9% , respectively (both p < 0.001). BMI decreased from 25.31 kg/m² to 24.65 kg/m².Exercise frequency increased from 2.83 times/week to 5.39 times/week; exercise duration increased from 20.03 min/d to 31.93 min/d; salt intake decreased from 9.56 g/d to 6.81 g/d; amount of cigarette smoking decreased from 11.31/d to 7.16 /d (all p < 0.005). TC decreased from 5.36 mmol/L to 4.65 mmol/L, LDL-C decreased from 3.35 mmol/L to 3.07 mmol/L (both p< 0.001), TG decreased from 1.79 mmol/L to 1.66 mmol/L (p= 0.021). CONCLUSIONS IFOC is an effective model in the management of hypertension and should be promoted and popularized by the Community Health Service Center in China as well as in other developing countries.

scholarly journals A COMPARATIVE STUDY OF EFFICACY AND SAFETY AMONG METFORMIN WITH SITAGLIPTIN, METFORMIN WITH VOGLIBOSE, AND METFORMIN WITH GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

2017 ◽  
Vol 10 (12) ◽  
pp. 313
Author(s):  
Kala P ◽  
Jamuna Rani R ◽  
Kumar Js
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Plasma Glucose ◽  
P Value ◽  
Efficacy And Safety ◽  
Group Iii ◽  
Group I ◽  
Group Ii

Objective: Type 2 diabetes mellitus (DM) is a most common metabolic disorder. The present study aimed to compare the efficacy and safety among metformin with sitagliptin, metformin with voglibose, and metformin with glimepiride in patients with type 2 DM. Methods: This study was a prospective, randomized clinical trial study, conducted in patients attending the diabetology outpatient department of SRM Medical College Hospital and Research Center, Potheri, Kancheepuram, Tamil Nadu, from January 2013 to January 2014. The patients were randomized into three groups with 40 patients in each group. Fasting plasma glucose (FPG), 2 hrs postprandial plasma glucose (PPG), and hemoglobin A1c (HbA1c) level were assessed in all the patients before starting the treatment. In Group I, patients were prescribed metformin 500 mg with sitagliptin 50 mg, in Group II, patients were given metformin 500 mg with voglibose 0.2 mg, and in Group III, patients were put on metformin 500 mg with glimepiride 1 mg in the fixed combination. The outcome of the therapy was based on the level of improvement in the blood parameters. Results: There was a significant reduction of FPG level seen in all three groups (p value - Group I <0.0001, Group II < 0.005, and Group III <0.0001). Group I and III showed significant reduction of PPG with p value <0.0001. There was a significant reduction of HbA1c seen in all the three groups (p<0.0001). Conclusion: From the results of this study, it could be concluded that all the three groups were comparable in their efficacy.

Sign in / Sign up

Export Citation Format

Share Document